Cresco Labs Statistics
Total Valuation
Cresco Labs has a market cap or net worth of CAD 491.22 million. The enterprise value is 1.09 billion.
| Market Cap | 491.22M |
| Enterprise Value | 1.09B |
Important Dates
The last earnings date was Thursday, March 5, 2026.
| Earnings Date | Mar 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Cresco Labs has 363.87 million shares outstanding. The number of shares has increased by 2.76% in one year.
| Current Share Class | 347.09M |
| Shares Outstanding | 363.87M |
| Shares Change (YoY) | +2.76% |
| Shares Change (QoQ) | +1.22% |
| Owned by Insiders (%) | 12.71% |
| Owned by Institutions (%) | 3.76% |
| Float | 302.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.55 |
| PB Ratio | 1.42 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 9.49 |
| P/OCF Ratio | 4.92 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.17, with an EV/FCF ratio of 21.10.
| EV / Earnings | -5.88 |
| EV / Sales | 1.21 |
| EV / EBITDA | 5.17 |
| EV / EBIT | 10.33 |
| EV / FCF | 21.10 |
Financial Position
The company has a current ratio of 2.59, with a Debt / Equity ratio of 2.31.
| Current Ratio | 2.59 |
| Quick Ratio | 0.96 |
| Debt / Equity | 2.31 |
| Debt / EBITDA | 3.79 |
| Debt / FCF | 15.47 |
| Interest Coverage | 1.28 |
Financial Efficiency
Return on equity (ROE) is -43.72% and return on invested capital (ROIC) is 9.32%.
| Return on Equity (ROE) | -43.72% |
| Return on Assets (ROA) | 3.78% |
| Return on Invested Capital (ROIC) | 9.32% |
| Return on Capital Employed (ROCE) | 7.03% |
| Weighted Average Cost of Capital (WACC) | 10.08% |
| Revenue Per Employee | 310,084 |
| Profits Per Employee | -64,021 |
| Employee Count | 2,900 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 3.64 |
Taxes
In the past 12 months, Cresco Labs has paid 61.18 million in taxes.
| Income Tax | 61.18M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +29.81% in the last 52 weeks. The beta is 1.64, so Cresco Labs's price volatility has been higher than the market average.
| Beta (5Y) | 1.64 |
| 52-Week Price Change | +29.81% |
| 50-Day Moving Average | 1.52 |
| 200-Day Moving Average | 1.35 |
| Relative Strength Index (RSI) | 47.85 |
| Average Volume (20 Days) | 111,146 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Cresco Labs had revenue of CAD 899.24 million and -185.66 million in losses. Loss per share was -0.52.
| Revenue | 899.24M |
| Gross Profit | 445.02M |
| Operating Income | 105.73M |
| Pretax Income | -130.84M |
| Net Income | -185.66M |
| EBITDA | 172.52M |
| EBIT | 105.73M |
| Loss Per Share | -0.52 |
Balance Sheet
The company has 79.39 million in cash and 800.96 million in debt, with a net cash position of -721.57 million or -1.98 per share.
| Cash & Cash Equivalents | 79.39M |
| Total Debt | 800.96M |
| Net Cash | -721.57M |
| Net Cash Per Share | -1.98 |
| Equity (Book Value) | 346.21M |
| Book Value Per Share | 1.30 |
| Working Capital | 218.14M |
Cash Flow
In the last 12 months, operating cash flow was 99.94 million and capital expenditures -48.18 million, giving a free cash flow of 51.76 million.
| Operating Cash Flow | 99.94M |
| Capital Expenditures | -48.18M |
| Free Cash Flow | 51.76M |
| FCF Per Share | 0.14 |
Margins
Gross margin is 49.49%, with operating and profit margins of 11.76% and -20.65%.
| Gross Margin | 49.49% |
| Operating Margin | 11.76% |
| Pretax Margin | -14.55% |
| Profit Margin | -20.65% |
| EBITDA Margin | 19.19% |
| EBIT Margin | 11.76% |
| FCF Margin | 5.76% |
Dividends & Yields
Cresco Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.76% |
| Shareholder Yield | -2.76% |
| Earnings Yield | -37.80% |
| FCF Yield | 10.54% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cresco Labs has an Altman Z-Score of -0.64 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.64 |
| Piotroski F-Score | 4 |